|
Volumn 144, Issue 1, 2007, Pages 46-48
|
Study of antidiabetic activity of a new ultralow-dose antibody preparation on the model of streptozotocin diabetes in rats
|
Author keywords
Diabetes mellitus; Glybenclamide; Insulin; Streptozotocin
|
Indexed keywords
ANTIDIABETIC AGENT;
GLIBENCLAMIDE;
GLUCOSE;
INSULIN RECEPTOR ANTIBODY;
NEUTRAL INSULIN;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ARTICLE;
BETA CHAIN;
CONTROLLED STUDY;
GLUCOSE BLOOD LEVEL;
GLUCOSE TOLERANCE;
INSULIN DEPENDENT DIABETES MELLITUS;
LOW DRUG DOSE;
MALE;
NON INSULIN DEPENDENT DIABETES MELLITUS;
NONHUMAN;
POLYDIPSIA;
RAT;
SINGLE DRUG DOSE;
STOMACH TUBE;
STREPTOZOCIN DIABETES;
SURVIVAL;
TREATMENT DURATION;
WEIGHT GAIN;
WEIGHT REDUCTION;
ANIMALS;
ANTIBODIES;
BLOOD GLUCOSE;
DIABETES MELLITUS, EXPERIMENTAL;
GLUCOSE TOLERANCE TEST;
HYPOGLYCEMIC AGENTS;
MALE;
RATS;
RECEPTOR, INSULIN;
ANIMALIA;
RATTUS;
|
EID: 36348971132
PISSN: 00074888
EISSN: None
Source Type: Journal
DOI: 10.1007/s10517-007-0250-4 Document Type: Article |
Times cited : (3)
|
References (12)
|